A detailed history of Alley Investment Management Company, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Alley Investment Management Company, LLC holds 114,847 shares of ABBV stock, worth $19.6 Million. This represents 2.87% of its overall portfolio holdings.

Number of Shares
114,847
Previous 114,237 0.53%
Holding current value
$19.6 Million
Previous $19.6 Million 15.75%
% of portfolio
2.87%
Previous 2.68%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $99,942 - $121,591
610 Added 0.53%
114,847 $22.7 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $63,618 - $74,292
411 Added 0.36%
114,237 $19.6 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $258,588 - $294,637
-1,618 Reduced 1.4%
113,826 $20.7 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $154,112 - $173,566
-1,120 Reduced 0.96%
115,444 $17.9 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $59,313 - $68,664
444 Added 0.38%
116,564 $17.4 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $59,231 - $73,710
-447 Reduced 0.38%
116,120 $15.6 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $305,705 - $352,065
2,114 Added 1.85%
116,567 $18.6 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $24,619 - $29,524
-178 Reduced 0.16%
114,453 $18.5 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.0%
114,631 $15.4 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $31,652 - $40,240
-230 Reduced 0.2%
114,628 $17.6 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $15.2 Million - $18.8 Million
114,858 New
114,858 $18.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alley Investment Management Company, LLC Portfolio

Follow Alley Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alley Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alley Investment Management Company, LLC with notifications on news.